{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:58:34Z","timestamp":1790935114357,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG076789"],"award-info":[{"award-number":["U01 AG076789"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ekir.2026.106700","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:32:45Z","timestamp":1784205165000},"page":"106700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol"],"prefix":"10.1016","volume":"11","author":[{"given":"Mohan Sonu","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Gagliano-Juc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skand","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol M.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Travison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran F.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy K.","family":"Latham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Meritus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilean","family":"Isaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusnie M.","family":"Beleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalender","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106700_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ekir.2026.106700_bib2","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.12.001","article-title":"US renal data system 2022 annual data report: epidemiology of kidney disease in the United States","volume":"81","author":"Johansen","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106700_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ekir.2026.106700_bib5","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2026.106700_bib6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib7","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10157-024-02502-w","article-title":"Ability of NAD and Sirt1 to epigenetically suppress albuminuria","volume":"28","author":"Hasegawa","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.2020081188","article-title":"Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy","volume":"32","author":"Yasuda","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm.3363","article-title":"Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes","volume":"19","author":"Hasegawa","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106700_bib16","article-title":"Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106700_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106700_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib19","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1681\/ASN.2017111218","article-title":"Sirtuins in renal health and disease","volume":"29","author":"Morigi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104975","article-title":"NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease","volume":"299","author":"Myakala","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ekir.2026.106700_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","article-title":"Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice","volume":"24","author":"Mills","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2026.106700_bib22","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1073\/pnas.1417921112","article-title":"In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2026.106700_bib23","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ekir.2026.106700_bib24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Canto","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2026.106700_bib25","article-title":"NAD(+) homeostasis in diabetic kidney disease","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106700_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08878","article-title":"Mitochondria-targeted drugs for diabetic kidney disease","volume":"8","author":"Mima","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ekir.2026.106700_bib27","article-title":"NMN protects cisplatin-associated AKI via NAD(+)\/SIRT1 pathway","volume":"17","author":"Wen","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2026.106700_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1210\/endrev\/bnad019","article-title":"Nicotinamide adenine dinucleotide in aging biology: potential applications and many unknowns","volume":"44","author":"Bhasin","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ekir.2026.106700_bib29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ekir.2026.106700_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1101\/sqb.2011.76.010629","article-title":"Sirtuins, aging, and metabolism","volume":"76","author":"Guarente","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.ekir.2026.106700_bib31","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1126\/science.289.5487.2126","article-title":"Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae","volume":"289","author":"Lin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ekir.2026.106700_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ekir.2026.106700_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2026.106700_bib34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","article-title":"De novo NAD(+) biosynthetic impairment in acute kidney injury in humans","volume":"24","author":"Poyan Mehr","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106700_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/gerona\/glac049","article-title":"MIB-626, an oral formulation of a microcrystalline unique polymorph of beta-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults","volume":"78","author":"Pencina","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ekir.2026.106700_bib36","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1210\/clinem\/dgad027","article-title":"Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: a physiologic study","volume":"108","author":"Pencina","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2026.106700_bib37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.advnut.2023.08.008","article-title":"The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update","volume":"14","author":"Song","year":"2023","journal-title":"Adv Nutr"},{"key":"10.1016\/j.ekir.2026.106700_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18272-y","article-title":"Safety evaluation of beta-nicotinamide mononucleotide oral administration in healthy adult men and women","volume":"12","author":"Fukamizu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106700_bib53","series-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"10.1016\/j.ekir.2026.106700_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41591-025-04057-z","article-title":"A meta-analysis of albuminuria as a surrogate endpoint for kidney failure","volume":"32","author":"Heerspink","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106700_bib40","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106700_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/dom.12600","article-title":"Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial","volume":"18","author":"Heerspink","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ekir.2026.106700_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2010.08.009","article-title":"Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD","volume":"57","author":"Methven","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106700_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106700_bib44","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1532-5415.2008.01927.x","article-title":"Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men","volume":"56","author":"Storer","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ekir.2026.106700_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ekir.2026.106700_bib46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106700_bib47","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106700_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","article-title":"Impairment of an endothelial NAD(+)-H(2)S signaling network is a reversible cause of vascular aging","volume":"173","author":"Das","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ekir.2026.106700_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2213-8587(19)30086-5","volume":"7","author":"Pollock","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106700_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10157-020-01963-z","article-title":"Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose-response study and open-label extension study","volume":"25","author":"Wada","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2026.106700_bib52","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:42:11Z","timestamp":1790934131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926029323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2468024926029323"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106700","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106700"}}